LY3325656
LY3325656 is a GPR142 agonist with demonstrated anti-diabetic efficacy in preclinical models, showing suitable ADME/PK for human use. It is the first molecule of its class to enter Phase 1 clinical trials for Type 2 diabetes, following studies confirming its in vitro receptor activation and in vivo glucose-lowering effects in animal studies.
Product Specifications
CAS Number
1998714-25-2
Smiles
CC1=C (N (C) C=N1) C=2NC (=NN2) [C@@H]3C[C@H] (N (C (=O) C4=CC (C (F) (F) F) =CC=C4) C) CCO3
Molecular Formula
C21H23F3N6O2
Molecular Weight
448.44
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL312339V 500 µL Each
HRG Human shRNA Lentiviral Particle (Locus ID 3273)
Sign In for Pricing
View Details